API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Domperidone SR Pellets are formulated to provide a controlled and sustained release of domperidone, a dopamine D2 receptor antagonist. It enhances gastrointestinal motility and accelerates gastric emptying. The SR formulation ensures prolonged therapeutic effect, reduced dosing frequency, and improved patient compliance.
| Component | Function |
|---|---|
| Domperidone | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Ethyl Cellulose / Eudragit RS/RL | Sustained release polymer – controls drug release |
| Triethyl Citrate / PEG 6000 | Plasticizer (for coating) |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Domperidone SR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
The SR pellets provide a sustained and controlled release of the drug, ensuring longer therapeutic activity, reduced dosing frequency, and improved patient compliance.
They are mainly filled into capsules or compressed into tablets to develop sustained release oral dosage forms.
They are widely used for managing nausea, vomiting, bloating, delayed gastric emptying, and functional dyspepsia, where prolonged gastric motility support is needed.
Yes, when manufactured under cGMP guidelines and supported with stability data, validated methods (USP/BP/EP), and proper regulatory documentation, they can be exported to both regulated and semi-regulated markets.